Figure 1: Absolute risk reduction due to one blood pressure lowering medicine vs. a moderate-strength statin in every study participant with 7.5%–15% 10-year risk by probability that their event would be a stroke.

Each dot is a study participant, the lines represent the linear regression of the relationship between percentage of events that are predicted to be strokes and the absolute risk reduction of any ASCVD event in 10 years.